2020 Pulmonary Embolism PIPELINE HIGHLIGHTS Pulmonary Embolism is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Pulmonary Embolism medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Global Pulmonary Embolism market presents promising new product pipeline with NME Projects, pivotal trials, and rapidly phase-advancing therapeutic candidates. Increasing number of companies are assessing the feasibility of developing treatment options for Pulmonary Embolism.
Good progress is anticipated during 2020 and 2021 with Pulmonary Embolism pipeline molecules advancing from pre-clinical investigation to completion of advanced Phase clinical trials. Pulmonary Embolism pipeline continues to expand and progress with novel mechanisms and diverse routes of administration being tested by companies.
Pulmonary Embolism DRUG DEVELOPMENT PIPELINE OVERVIEW The “Pulmonary Embolism pipeline Research Monitor, 2020” report is an analytical research study on the progress achieved by pipeline companies during the year along with its historical development, current status, and outlook.
This Pulmonary Embolism pipeline review explores high-potential early to late-stage pipeline projects with a continued focus on new insights, accelerated processes, and pipeline progression.
The competitive intelligence report on Pulmonary Embolism presents detailed insights into therapeutic drug pipeline development, industry news, deals, and analysis across the length and breadth of the Pulmonary Embolism pipeline. Information on R&D pipeline updates, results of key clinical trials are also included in the report.
Pulmonary Embolism DRUG PROFILES
Pulmonary Embolism development pipeline including projects in early- and late-stage development are detailed in the report. Details of clinical trial data and submissions to regulatory authorities are also provided. For the drug candidates included in the report, the following information is provided- • Current Status of Development including phase advancements, regulatory approvals of phases, acquisitions, licensing and technology transfers, product launches in various markets, and others.
• Phase of development • Mechanism of Action • Route of Administration • Companies involved including originator, licensing companies, developer, investors, and others • New molecular entity details • Orphan drug designation and other special status provided by regulators
Pulmonary Embolism COMPANY PROFILES Both small size and large size pharmaceutical companies are investing their resources in Pulmonary Embolism drug development operations. Further, financial institutions are extending support to small pharmaceutical companies, universities, and other researchers for the development of treatment of Pulmonary Embolism. Partnerships and acquisitions are also increasingly observed in the pipeline.
This research report presents an analysis of 8 Pulmonary Embolism companies including company overview, key snapshot, contact information, and their strategies on accelerating Pulmonary Embolism pipeline development. Mid-stage and early portfolios of these companies are analyzed in detail in the report.
Companies analyzed in the report include- Acticor Biotech SAS, Daiichi Sankyo Co Ltd, Indiana Lysis Technologies LLC, Les Laboratoires Servier SAS, Tasly Pharmaceutical Group Co Ltd, TeaRx Ltd, Valeo Pharma Inc, Verseon Corp
Reasons to Buy • The current market conditions are forcing companies and investors worldwide to prioritize their investments and accelerate pipeline candidates only through careful quantitative assessment.
• This research work assists decision makers in pharmaceutical companies towards successful pipeline development through critically evaluated pipeline data • Buyers can identify most promising drug candidates for treatment of Pulmonary Embolism • It allows users to strengthen their pipeline through acquisitions, licensing and collaborations • Users can estimate possible delays in the delivery of pipeline or launch of new products • Stay ahead of competition through understanding their pipeline progression, strategies and outlook • The report details all the pipeline candidates under investigation in various stages of development from Phase I through to Phase III to enable business development managers to understand the impact of new launches.
• Optimize your licensing and technology transfer strategies through identification of prospect partners
Our reports have been used by over 10K customers, including:
The North America Topical Dispenser Market would witness market growth of 7.5% CAGR during the forecast period (2020-2026). Topical applicators are designed with a motive of easy application of ointments, gels, creams, masks, peels, skin protectants, disinfectants, and pharmaceuticals. With the increasing development in the field of...
Summary Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems.The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, in-office procedures, essential...
Oncology Market Access Europe – Payer and Industry Perspectives answers your questions: What are payers looking for when making decisions regarding oncology reimbursement? How are HTAs and other challenges affecting market access...
110 pages •
By Persistence Market Research
• Apr 2015
Cleanroom technology is used for the manufacture of aseptic medical goods or for research and development purposes. Cleanroom refers to an enclosed space maintained in such a way so as to reduce contamination during processing. They can control the concentration of airborne particles such as particulates (including dust, hair, and skin), chemicals...
85 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Aug 2015
This Future Market Insights report examines the ‘Global Automated CPR Devices” market for the period 2014 - 2025. The primary objective of the report is to offer updates on the advancement of automated CPR devices, examining the marketing efforts and to provide the market opportunities in the global automated CPR Devices Market. The...
193 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Oct 2016
Intraosseous infusion devices are emergency medical products intended for managing life threatening conditions. These products are generally used when there is no access to veins for desired infusion. Intraosseous vascular access is a rapid and alternative method for immediate medical intervention during emergency situations. The global intraosseous...
Wide Area Ambulatory Patient Monitors In today’s connected world, there is a growing need for remote medical care services and wireless fitness monitoring capabilities. The latest advances in smartphones and wired and wireless communication technologies are making this connectivity possible. For patients, linking selfmonitoring devices...
220 pages •
By Transparency Market Research
• Feb 2018
Global Microbial Fermentation Technology Market: Overview This report on the microbial fermentation technology market analyzes the current and future scenario of the global market.Growth of the global microbial fermentation technology market is driven by wide use of fermentation technology derived chemicals in various industries...
The Global Parcel Sortation Systems Market size is expected to reach $2.0 billion by 2023, rising at a market growth of 9.1% CAGR during the forecast period. Automated sortation system is considered as a major breakthrough in the mechanical sector. Automation is used in sorting number of consumer products such as packaged food & beverages,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.